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Abstract
Background: Avoidance of allergens is still recommended as the first and best way to prevent
allergic illnesses and their comorbid diseases. Despite a variety of attempts there has been very
limited success in the area of environmental control of allergic disease. Our objective was to
identify a non-invasive, non-pharmacological method to reduce indoor allergen loads in atopic
persons' homes and public environments. We employed a novel in vivo approach to examine the
possibility of using aluminum sulfate to control environmental allergens.
Methods: Fifty skin test reactive patients were simultaneously skin tested with conventional test
materials and the actions of the protein/glycoprotein modifier, aluminum sulfate. Common
allergens, dog, cat, dust mite, Alternaria, and cockroach were used in the study.
Results: Skin test reactivity was significantly reduced by the modifier aluminum sulfate. Our studies
demonstrate that the effects of histamine were not affected by the presence of aluminum sulfate.
In fact, skin test reactivity was reduced independent of whether aluminum sulfate was present in
the allergen test material or removed prior to testing, indicating that the allergens had in some way
been inactivated.
Conclusion: Aluminum sulfate was found to reduce the in vivo allergic reaction cascade induced
by skin testing with common allergens. The exact mechanism is not clear but appears to involve
the alteration of IgE-binding epitopes on the allergen. Our results indicate that it may be possible
to diminish the allergenicity of an environment by application of the active agent aluminum sulfate,
thus producing environmental control without complete removal of the allergen.
Background
The various clinical manifestations of type 1 hypersensi-
tivities and their resultant comorbid illnesses are well
known. A common feature shared by these is the mecha-
nism by which they are induced, driven by cytokines pro-
duced by Th2 lymphocytes, resulting in IgE antibody
production. Antigen specific IgE antibodies cause multi-
ple preformed mediators to be released from mast cells
and blood basophils. These preformed cytokines interact
with their receptors on target cells inducing a cascade of
reactions with late phase mediator formation, leading to
sustained symptoms [1]. Consequently, anything that
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Table 1: Patient skin test reactions to allergens and allergens mixed with AS. Summary of patient skin prick responses to dog, cat, 
mite, Alternaria, and cockroach allergens. Responses to 100% allergen, 90% allergen + 10% diluent, 90% allergen + 10% ASα, or 90% 
allergen + 10% ASβ were scored as follows: (+) = 3 to 5 mm wheal; (++) = 5 to 7 mm wheal; (+++) = 7 to 10 mm wheal; (++++) = 10 mm 
or greater wheal; E = erythema; P = pseudopod.
Patient Allergen Type 100% Allergen 90% Allergen + 10% 
Diluent
90% Allergen + 10% 
AS α
90% Allergen + 10% 
AS β
1 Mite ++++EP (20 mm W) ++++EP (25 mm W) ++++EP (13 mm W) ++++EP (12 mm W)
2 Alternaria +++ (7 mm W) +++ (8 mm W) + (3 mm W) 0
3 Mite ++++ ++ (5 mm W) 0 (2 mm E) 0
Cockroach ++++ ++ (6 mm W) + (3 mm W) + (4 mm W)
4 Cat ++++E (21 mm W) ++E (6 mm W) 0 0
Mite ++++E (16 mm W) + (3 mm W) + (4 mm W) 0
5 Cockroach ++++E ++ ++ 0
6 Cockroach ++++E ++ ++ 0
7 Cat +++ ++ + 0
8 Cat ++++ ++++ ++++ 0
Mite ++++ ++++ ++++ 0
9 Cat ++++ (20 mm W) + (3 mm W) 0 0
Dog ++++ (20 mm W) + (3 mm W) + (3 mm W) 0
Alternaria +++E (7 mm W) ++ (4 mm W) 0 0
10 Cat ++++EP (10 mm W) ++++EP (9 mm W) ++ (5 mm W) 0
11 Cat ++++EP (10 mm W) ++E (5 mm W) ++E (5 mm W) 0 (1 mm W)
Dog ++++EP (10 mm W) ++++EP (9 mm W) ++E (5 mm W) ++E (5 mm W)
Mite +++ (7 mm W) +++ (7 mm W) + (3 mm W) 0 (1 mm W)
12 Cat ++++ (14 mm W) ++++ (14 mm W) ++++ (14 mm W) +++ (6 mm W)
Dog ++++ (10 mm W) ++++ (14 mm W) + (3 mm W) + (3 mm W)
Alternaria ++++ (11 mm W) ++++ (10 mm W) +++ (7 mm W) 0
Mite ++++ (10 mm W) +++ (7 mm W) +++ (7 mm W) + (3 mm W)
Cockroach ++++ (12 mm W) ++++ (10 mm W) ++ (6 mm W) + (4 mm W)
13 Cat ++++PE (15 mm W) ++++ (11 mm W) ++++ (12 mm W) + (3 mm W)
Mite ++++E (19 mm W) +++ (9 mm W) +++ (9 mm W) ++ (5 mm W)
14 Cat +++ + (4 mm W) ++ (5 mm W) + (4 mm W)
Alternaria +++ + (4 mm W) + (3 mm W) 0
Mite ++++ ++++ (13 mm W) ++++ (10 mm W) ++ (6 mm W)
15 Mite +++ (8 mm W) ++ (5 mm W) + (3 mm W) + (3 mm W)
16 Cat ++++ (11 mm W) ++++ (18 mm W) ++++ (12 mm W) ++++ (16 mm W)
Alternaria ++++ (21 mm W) +++ (8 mm W) ++ (7 mm W) + (4 mm W)
Mite +++ (10 mm W) ++ (6 mm W) ++ (5 mm W) + (3 mm W)
17 Cat ++++EP (12 mm W) ++++EP (13 mm W) +++E (8 mm W) +++E (7 mm W)
Mite ++++E (10 mm W) ++++E (10 mm W) +++E (8 mm W) +++E (6 mm W)
18 Mite ++++EP (15 mm W) +++E (8 mm W) ++E (5 mm W) ++E (5 mm W)
19 Mite ++++E (10 mm W) +++E (8 mm W) ++ (6 mm W) + (3 mm W)
20 Mite ++++EP (23 mm W) ++ (6 mm W) ++++ (11 mm W) + (3 mm W)
21 Cat ++++EP (11 mm W) ++++EP (11 mm W) +++EP (8 mm W) +++EP (8 mm W)
Alternaria ++++ +++ + +
Mite ++++EP + + +
22 Mite ++++E (9 mm W) +++E (7 mm W) ++E (4 mm W) +E (3 mm W)
23 Alternaria ++++ ++ (3 mm W) ++ (3 mm W) 0
Mite + +++E (7 mm W) +++E (7 mm W) 0 (1 mm W)
24 Mite +++E + 0 0
Cockroach +++E 0 0 0
25 Mite +++ +++ + ++
Cockroach ++++E +++E + +E
26 Cat ++++E (20 mm W) ++++E (13 mm W) ++++E (11 mm W) ++++E (19 mm W)
Mite ++++ (10 mm W) ++E (5 mm W) +E (4 mm W) +E (3 mm W)
Cockroach ++++ (15 mm W) +++ 0 E 0
27 Cat ++++ (10 mm W) ++++ (10 mm W) 0 0
Mite ++++ (10 mm W) ++++ (10 mm W) ++++ (10 mm W) ++++ (10 mm W)
Cockroach ++++ (10 mm W) ++++ (10 mm W) 0 + (3 mm W)
28 Cockroach ++++ (10 mm W) ++++ (10 mm W) +++ (7 mm W) ++ (6 mm W)
29 Cockroach +E +E 0 0
30 Cockroach ++++ (10 mm W) +++ (7 mm W) + (3 mm W) 0Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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effectively interferes with or blocks the release of these
mediators is of considerable interest in the prevention of
allergic disease. Currently, methods employed for this
purpose include pharmacological therapy, immuno-
therapy and avoidance of allergen(s). Although these
applications have been of clinical benefit, they have not
significantly lowered the number of new allergy cases and
in particular asthmatics, numbering 16 million or 7.5% of
the U.S. adult population [2]. This has been due to the dif-
ficulty reducing or preventing exposure to multiple ubiq-
uitous environmental allergens [3]. Thus, any method(s)
that effectively eliminates or greatly reduces these aller-
gens from areas of exposure would have far reaching
health benefits, reducing the mortality and morbidity bur-
den of atopic individuals [4].
Although various attempts have been made to control
environment allergens, most have met only limited suc-
cess [5,6]. Chemicals such as tannic acid and sodium
hypochlorite have been reported to form complexes with
environmental allergens reducing their ability to trigger
allergic reactions [6-12]. Unfortunately, these substances
produce undesirable side effects such as unacceptable
damage to treated surfaces. Acaricides applied to interior
surfaces have proven to be unacceptable controls for dust
mite allergens [13]. Sustained use of removal techniques
for environmental control is met by most patients with
resistance, especially where family pets are concerned
[14]. Air filtration only picks up airborne allergens if they
reach the filter before the patient, and constant vigilance
of their function is imperative [15]. Filters which are too
dense, result in poor air circulation and thereby reduced
efficacy [16].
In this study, we employed a novel in vivo approach to
examine the possibility of using aluminum sulfate (AS),
to control environmental allergens and to inhibit allergic
reactions. This chemical seemed to be a good candidate
for this purpose because of its ability to bind to proteins
[17], its long lasting residual effect, and its lack of toxicity
[18,19]. Because of these functional properties, and the
fact that allergens are for the most part composed of pro-
teins or glycoproteins, we hypothesized that AS would
interact with allergens. This interaction in turn would pre-
vent them from triggering an allergic response by blocking
their ability to bind with their specific IgE antibodies. This
would eliminate a critical step in the allergic response cas-
cade that generates the various clinical manifestations
commonly associated with type 1 hypersensitivities. The
results of this study demonstrate that AS can indeed inac-
tivate a variety of allergens, blocking their ability to induce
wheal and flare skin reactions in allergic individuals. This
suggests that AS can be employed as an agent to interact
with and inactivate environmental allergens.
31 Cockroach +++ (8 mm W) ++ (5 mm W) + (3 mm W) + (3 mm W)
32 Cat ++++ (10 mm W) +++ (8 mm W) +++ (8 mm W) 0
Dog ++++ (10 mm W) +++ (7 mm W) +++ (7 mm W) + (5 mm W)
33 Cockroach ++ (6 mm W) ++ (6 mm W) + (3 mm W) 0
34 Cat ++++ (10 mm W) ++++ (14 mm W) ++ (6 mm W) ++ (7 mm W)
Dog ++++ (10 mm W) ++++ (10 mm W) 0 0
35 Cat ++++ (18 mm W) +++ (7 mm W) + (3 mm W) + (3 mm W)
Dog ++++ (10 mm W) ++ (4 mm W) + (3 mm W) ++ (4 mm W)
36 Dog ++++E (12 mm W) +++E (9 mm W) ++E (5 mm W) +E (4 mm W)
37 Cat ++++E (10 mm W) ++++E (10 mm W) +++ (7 mm W) + (4 mm W)
Dog ++++EP (14 mm W) ++++EP (12 mm W) 0 0
38 Cat ++++ (11 mm W) ++++EP (13 mm W) ++ (6 mm W) + (3 mm W)
39 Alternaria +++E (8 mm W) +++E (9 mm W) ++ (5 mm W) + (4 mm W)
40 Alternaria ++++E (13 mm W) ++++E (11 mm W) +++E (7 mm W) 0
41 Cat +++ (8 mm W) +++ (7 mm W) ++ (6 mm W) ++ (5 mm W)
42 Cat ++++E ++++E + ++
43 Cat +++ (8 mm W) ++ (6 mm W) ++ (5 mm W) + (4 mm W)
Dog ++++ (11 mm W) ++ (5 mm W) + (4 mm W) + (4 mm W)
44 Alternaria ++++EP (12 mm W) ++++EP (12 mm W) +++E (9 mm W) ++E (8 mm W)
45 Cat ++++EP +++ ++ +
Alternaria ++++EP ++ ++ +
46 Cat ++E ++E 0 +E
Dog ++E (5 mm W) ++E (6 mm W) ++E (6 mm W) +
47 Alternaria ++++E (10 mm W) +++E (7 mm W) ++E (6 mm W) +E (4 mm W)
48 Cat ++++E ++++E + 0
49 Dog +++E + + ++
50 Cat ++++EP (10 mm W) ++++EP (10 mm W) +++E (8 mm W) +++E (7 mm W)
Table 1: Patient skin test reactions to allergens and allergens mixed with AS. Summary of patient skin prick responses to dog, cat, 
mite, Alternaria, and cockroach allergens. Responses to 100% allergen, 90% allergen + 10% diluent, 90% allergen + 10% ASα, or 90% 
allergen + 10% ASβ were scored as follows: (+) = 3 to 5 mm wheal; (++) = 5 to 7 mm wheal; (+++) = 7 to 10 mm wheal; (++++) = 10 mm 
or greater wheal; E = erythema; P = pseudopod. (Continued)Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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Methods
Patient selection
Individuals were recruited from a large private allergy
practice in Louisville, KY, between 1999 and 2005. The
age range was from 10 to 66 yrs. These patients had clini-
cal symptoms of rhinitis, asthma, conjunctivitis, chronic
sinusitis or a combination of 2 or more of the manifesta-
tions of Type I hypersensitivity reactions. The protocol to
be used in the study was explained in detail to the patients
and they were given the option of participating in the
study, informed consent was granted. If their prescribed
routine allergy skin test produced a high level of reactivity
to one of the selected test antigens they were included in
the study groups. No volunteer was compensated mone-
tarily or otherwise for his or her participation and no
funding for the study came from outside sources.
Aluminum sulfate solution preparations
Aluminum sulfate, Al2(SO4)3, (Sigma/Aldrich, St. Louis)
was prepared by dissolving proper aliquots in sterile
water. Using the same diluent as for the allergens (normal
saline), 8.75% (ASα) and 34.2% (ASβ) solutions of the
chemical were prepared. Prior to use, they were filtered
using a micropore filter #4, placed in sterile containers,
and stored at 4°C until used in skin test.
Toxicity testing
Toxicity tests were performed using cultured human
endothelial cells (obtained from ATCC, Rockville, MD;
CRL 1730) and the trypan blue dye exclusion test to eval-
uate the safety of using AS in human applications [20].
Cells were incubated for 24 h with 1:10, 1:20, or 1:30
dilutions of ASβ, collected and examined microscopically
for dye uptake. A hemocytometer was used for quantita-
tion. Three separate tests were performed.
Allergens used
Initial screening of patients involved only routine inha-
lant skin test with the following allergens: animal dan-
ders, cockroach, dust mite, mold spores and pollens of
grasses, weeds and trees prevalent in the Ohio River Val-
ley. They were obtained from Greer Labs (Lenoir, NC) and
used at a standard prick test concentration. Those patients
who produced high skin reactions (when compared to the
diluent control, normal saline) to cat, dog, Alternaria,
dust mites, cockroach or multiples there of were selected
Selected patients were skin tested with allergens mixed with AS Figure 1
Selected patients were skin tested with allergens mixed with AS. Controls included allergens alone and saline. Means and stand-
ard deviations, as well as P-values, of data (clinical scores, see Methods) collected from the 50 patients are presented. P-values 
were determined using an unpaired two-tailed Student's t-test. A P-value of < 0.05 was considered statistically significant. 
Notice that AS markedly reduced skin test reactions to the allergens tested.Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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to undergo additional skin tests with these same allergens
mixed with AS. AS-allergen preparations were created by
mixing 0.1 ml ASα (8.75%) to 0.9 ml of the skin test dose
allergen or 0.1 ml ASβ (34.2%) to 0.9 ml of the skin test
dose allergen. No precipitate was observed upon mixing
of the allergen and AS. All skin reactions were read 20 min
after the prick test was applied.
Skin test evaluation
The diameter of the patients' skin test responses to aller-
gens or allergens mixed with AS were measured using skin
test calipers and recorded in terms of size in mm of indu-
ration (wheal size) at the largest diameter. Clinical score:
a conventional grading system of + to 4+ was also used as
determined by these parameters: (+) = 3 to 5 mm wheal;
(++) = 5 to 7 mm wheal; (+++) = 7 to 10 mm wheal;
(++++) = 10 mm or greater wheal; erythema (E) and pseu-
dopod (P) were also observed and recorded. P-values were
determined using an unpaired two-tailed Student's t-test
(< 0.05 was considered statistically significant).
Histamine
Histamine base solution (1.8 mg/ml and 50% glycerol wt/
vol), obtained from Allermed Labs (SanDiego, CA), was
injected intradermally alone and mixed with AS (at a con-
centration of 0.9% and 9.0%). Controls included 0.9%
NaCl, 0.4% phenol. After 20 min, lesion diameters were
measured as before using skin test calipers. In some cases,
reactive sites that had previously been injected with only
histamine, received a second injection with just AS. As
before, responses were read 20 min later.
Sample dialysis
Lyophilized cat dander was purchased from Greer Labs
(Lenoir, NC) and suspended in 100 microliters of sterile
water to a concentration of 29 mg/ml. Next, 15 microliters
was added to either 1 ml sterile water (sample 1) or 1 ml
9% AS (samples 2 & 3). Sample 1 was then dialyzed for 6
h against 1 liter of sterile water, sample 2 was dialyzed for
6 h against 1 liter of 9% AS, and sample 3 was dialyzed for
6 h against 1 liter of sterile water. Final allergen concentra-
tion was estimated to be approximately 50,000 BAU.
Samples were then used for skin testing in three patients
sensitized to cat allergen with inclusion of proper con-
trols, sterile water as sample 4 and 9% AS solution as sam-
ple 5. The experiment was repeated using Centricon
ultrafiltration devises (Millipore, 3K MW cutoff) as a dif-
ferent means to dialyze the samples. Dialysis was accom-
plished by addition of 2 ml of either 9% AS or water
following complete concentration of the samples, this was
repeated four times to ensure complete dialysis of the
samples was accomplished.
Results
Aluminum sulfate exhibited no toxicity
A preliminary experiment was done to determine if AS
exhibited any cellular toxicity. As previously noted, 1:10,
1:20, or 1:30 dilutions (diluted in normal saline) of ASβ
were placed in established human endothelial cell cul-
tures and incubated for 24 h with 5% CO2 at 37°C. Cells
were collected and a trypan blue dye exclusion test was
performed (see Methods section). The results indicate that
99.9% of the cells were still viable at the end of a 24 h
exposure to the chemical, for the dilutions tested. It
should also be noted here that no toxicity was observed in
vivo using the skin prick test.
Aluminum sulfate significantly reduces the allergen-
induced skin prick response
In this experiment, a group of 50 patients were used. They
were selected for testing with the AS-allergen mixtures
based on their level of sensitivity to routine allergy skin
tests. For this purpose, only those allergens that had
Aluminum sulfate does not block histamine Figure 3
Aluminum sulfate does not block histamine. Skin reactions at 
15 min are shown in panel (A). Skin reactions at 30 min are 
shown in panel (B). Within panels A and B, skin prick 
responses are shown to: saline (1), histamine (2), 0.9% AS 
(3), 9.0% AS (4), 0.9% AS + histamine (1.8 mg/ml) mixed at 
1:10 (AS:histamine) (5), and 9.0% AS + histamine (1.8 mg/ml) 
mixed at 1:10 (AS:histamine) (6). Skin reaction to 0.1 cc AS 
ID at 15 min is shown in panel (C) (site 7). Skin reaction 15 
min following overlay of site 7 in panel C with histamine (1.8 
mg/ml) is shown in panel (D). Notice that AS did not inhibit 
the histamine induced skin reaction.Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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induced a +4 reaction (10 mm or greater) were mixed with
AS for further skin testing. The allergens and their concen-
trations used are indicated in Table 1, and Figures 1 &2. A
compilation of the results, recorded for each patient,
appears in Table 1, while statistical analysis of this data is
presented in Figure 1. As can be seen, in comparison to
controls, significant decreases in skin reactivity (clinical
score) to cat (P < 0.007), dog (P < 0.003), Alternaria (P <
0.03), and cockroach (P < 0.003) allergens occurred by
the addition of AS. The given effect could be obtained by
using either 8.75% or 34.2% dilutions of the AS. Amaz-
ingly, an even greater difference in patient skin test reac-
tions were observed between sites receiving 90% allergen
+ 10% diluent ASα and those that received 90% allergen
+ 10% ASβ (in all cases P < 0.0005), demonstrating a dose
response effect. From the data presented, it is quite clear
that AS can interfere with mechanism(s) involved in type
1 hypersensitivity reactions. Clinically, the inhibitory
effects of AS in vivo can more readily be seen by the pho-
tographic evidence presented in Figure 2.
Aluminum sulfate does not block histamine effects
To determine if the observed AS induced reduction in STR
possibly resulted from interference with histamine activ-
ity, a patient received injections of either histamine or his-
tamine mixed with AS, as indicated (see Methods section).
The results indicate that histamine induced skin reactions
cannot be blocked by AS (Fig. 3). The size of the lesions
for histamine (14 mm) and histamine-AS mixture (12
mm) was essentially the same. The experiment was
repeated with the same results. This, in conjunction with
Wheal and flare responses in a patient skin tested with the cat allergen and cat allergen mixed with AS, as in Figure 1 Figure 2
Wheal and flare responses in a patient skin tested with the cat allergen and cat allergen mixed with AS, as in Figure 1. Hista-
mine and saline were included as controls. Reactions were read with no testing (A), 5 min (B), 15 min (C), and 30 min (D). 
Within each panel, skin prick responses are shown to: histamine (1), saline (2), 10% saline + 90% cat allergen (3), cat allergen 
(4), and 10% ASβ + 90% cat allergen (5). Wheals were measure by the aid of skin test calipers.Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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the above finding, strongly suggests that AS exerts its effort
by blocking allergen-IgE interactions.
Exposure to aluminum sulfate alters the allergen
In order to be sure that AS was altering the allergen, and
not modulating the hypersensitivity reaction by some
other mechanism, mast cell stabilization for example, a
simple experiment was performed. Cat allergen was
mixed with AS (as described in Methods section), dialyzed
against water to remove the AS, and then used for skin
testing in several sensitized patients. Results shown in Fig-
ure 4 clearly demonstrate that AS reduced the allergen-
induced skin prick response without being present in the
test material. The reduction in wheal was identical
between the sample containing AS and the sample which
contained no AS, only exposed to AS and dialyzed to
water. The experiment was repeated using Centricon ultra-
filtration devises (Millipore, 3K MW cutoff) to remove AS
from the samples with exactly the same results (data not
shown). This indicates that exposing the allergen to AS
results in alteration of its ability to induce a hypersensitiv-
ity reaction in sensitized patients.
Discussion
Approximately 16% of persons living in the United States
demonstrate an exaggerated tendency to mount IgE medi-
ated response to a wide variety of common environmental
allergens, leading to an estimated 1 of every 9 doctor visits
[21,22]. Consequently, treatment modalities and applica-
tions that would prevent or significantly reduce exposure
to such allergens are of considerable interest and impor-
tance [23]. In the past, attempts have been made by some
Exposure to aluminum sulfate alters the allergen Figure 4
Exposure to aluminum sulfate alters the allergen. Skin test results of three patients after 30 min are shown. Sample 1 contains 
cat allergen and water which was dialyzed against water and thus acts as a positive control. Sample 2 includes cat allergen and 
AS which was dialyzed against AS, thus the test sample contains AS. Sample 3 is cat allergen and AS which was dialyzed against 
water, therefore the test sample does not contain AS. Water and AS controls are also shown (samples 4 and 5 respectively). 
Representative photograph (patient 3) of skin test response after 30 min is also shown.Clinical and Molecular Allergy 2006, 4:1 http://www.clinicalmolecularallergy.com/content/4/1/1
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investigators to reduce exposure by using certain chemi-
cals known to bind to proteins [6-12]. For example, tannic
acid and sodium hypochloride have been found to inter-
act and form complexes with allergen-proteins [6-12].
Unfortunately, their use has been greatly limited due to
staining and bleaching properties respectively. In this
study, we examined and found that AS could be used to
significantly reduce type 1 hypersensitivity reactions to
several different allergens. Wheal and flare reactions to
cat, dog, mite, cockroach, and Alternaria allergens were
markedly inhibited by AS (Table 1, Fig. 1 &2). The mech-
anism(s) by which AS prevents allergens from interacting
with their antigen-binding site on specific IgE molecules,
bound to receptors on mast cells, remains unclear. One
might however, envision the formation of ionic allergen-
AS complexes or alteration of the allergen's protein struc-
ture by AS. Our experiments have demonstrated that
exposing the allergen to AS results in this effect; AS does
not have to be included in the test material to get the
reduction in skin test response (Fig. 4). In addition, pre-
liminary ELISA results show a reduction in allergen bind-
ing to specific monoclonal antibodies (data not shown).
Several patients' (patients #16 & 26 to cat and #27 to
mite) skin test results, however, did not appear to dimin-
ish with AS treatment of the allergen. These patients'
responses are likely artificial, since they represent only 3
of 83 test results. An alternative explanation could be that
the AS-altered allergen retains some epitopes which can
be recognized by a very small percentage of individuals.
Studies are currently underway to further elucidate the
mechanism(s) by which AS interferes with this important
interaction.
Aluminum sulfate does not appear to block histamine-
induced responses. Skin reactions were not influenced by
mixing AS with histamine or by injecting histamine into
sites previously injected with AS (Fig. 3). Its effects on
other mediators such as leukotrienes or proinflammatory
cytokines remain to be determined. Finally, it should be
noted that AS exhibits several properties that make it a
great candidate for environmental control of allergens. It
acts quickly; skin testing performed within 15 minutes of
adding AS to the allergen exhibits a diminished skin test
response. Allergen-AS mixtures are very stable, mixtures
stored for up to 3 months produced a similar reduced skin
reaction as those freshly prepared. Also it appears to lack
any detrimental toxicity as determined by in vitro testing
with cultured human endothelial cells and as indicated by
the lack of any significant skin reactivity in patients above
controls when injected alone. AS is inexpensive and does
not appear to stain or discolor carpeting or clothing.
Although our studies were done in the clinic, we feel that
similar inhibitory effects (blocking of allergic reactions)
will result from AS application to the environment. Active
investigation is currently underway to evaluate the effec-
tiveness AS have in inactivating allergens in the environ-
ment.
Conclusion
AS was found to significantly reduce the skin test response
in sensitized patients to each of the allergens tested: dust
mite, Alternaria, dog, cat, and cockroach. The exact mech-
anism in which AS produces this effect is not known.
However, our results demonstrate that AS does not block
the effects of histamine, and produces its effect without
being present in the skin test sample. It appears that AS
alters the allergen, changing its epitopes, thus reducing
the ability of specific IgE to bind and ultimately mast cell
degranulation. AS does not stain, is cheap, nontoxic, is
stable in solution, and appears to have long acting affects,
making it a great candidate for use as an environmental
control agent.
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